// App-Quantinova.ai

188 : Androgen-deprivation therapy plus docetaxel-based chemotherapy in metastatic hormone-sensitive prostate cancer. A meta-analysis of randomized clinical trials.

Researchers

Presenter

  • Allan Ramos-Esquivel

Principal Investigators

  • Joao M. Baptista

  • Luis Corrales-Rodriguez

  • Ileana Gonza°lez

  • Melissa Juarez Villegal

  • Zenen Zeledon

  • Cristina Ferna°ndez

Medical Centers

  • Hospital San Juan de Dios-Caja Costarricense Seguro Social, San Jose, Costa Rica

  • University of Costa Rica, Miami, FL, Costa Rica

  • Hospital San Juan de Dios - CCSS, Alajuela, Costa Rica

  • Hospital San Juan de Dios. Servicio de Oncología Médica, San José, Costa Rica

  • Hospital San Juan de Dios. Servicio de Oncología Médica, San José, Costa Rica

  • Hospital San Juan de Dios, San Jose, Costa Rica

  • Hospital San Juan de Dios. Servicio de Oncología Médica, San José, Costa Rica

Locations

  • Costa Rica

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

  • Androgen Tear

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved